Read oxford coronavirus vaccine latest news on The Economic Times. Oxford coronavirus vaccine updates, oxford coronavirus ...
The New Times on MSN
Potential vaccines being developed against Ebola
Several vaccines against Bundibugyo virus are being developed as scientists work to close a gap in Ebola protection. ALSO READ: First human trial begins for Bundibugyo Ebola vaccine The strain is ...
The Government has said it will invest £33.2m in eight projects to tackle overseas disease outbreaks that pose risks to the ...
Day four of the Innovation Festival looked outwards from Manchester to the world. At the inaugural Cambridge x Manchester ...
AstraZeneca (LSE:AZN) slips after Summit Therapeutics investment news and a new Boston site opening; sector context for UK pharma investors.
While levels of flu are currently low, figures from September have been higher than the same period for the last four years ...
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that Guardant360® CDx has received CE-marking under Europe’s in Vitro Diagnostic Medical Devices Regulation as ...
The Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine (MRC/UVRI & LSHTM Uganda Research ...
The Phase I trial is being carried out by the Medical Research Council/Uganda Virus Research Institute and the London School of Hygiene & Tropical.
Dr Koh brings extensive infectious disease and clinical development expertise as RQ Bio prepares to advance RQB01 into the ...
Summit Therapeutics Inc. (NASDAQ: SMMT) today announced the successful closing of AstraZeneca’s (LSE/STO/NYSE: AZN) strategic equity investment in Summit. The equity investment will support continued ...
AstraZeneca and Daiichi Sankyo will test their Datroway cancer drug alongside Summit Therapeutics' ivonescimab, starting with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results